title: Which cyclosporin formulation?
authors.forename: W M
authors.initials: WM
authors.lastname: Bennett
authors.forename: A
authors.initials: A
authors.lastname: DeMattos
authors.forename: D J
authors.initials: DJ
authors.lastname: Norman
authors.forename: M M
authors.initials: MM
authors.lastname: Meyer
authors.forename: A
authors.initials: A
authors.lastname: Olyaei
mesh_terms: D001682:Biological Availability; D016572:Cyclosporine / Q000493:pharmacokinetics* / Q000627:therapeutic use; D005260:Female; D006084:Graft Rejection; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D013810:Therapeutic Equivalency
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine